Etomidate Suppresses Invasion and Migration of Human A549 Lung Adenocarcinoma Cells.

Related Articles

Etomidate Suppresses Invasion and Migration of Human A549 Lung Adenocarcinoma Cells.

Anticancer Res. 2019 Jan;39(1):215-223

Authors: Chu CN, Wu KC, Chung WS, Zheng LC, Juan TK, Hsiao YT, Peng SF, Yang JL, Ma YS, Wu RS, Chung JG

Abstract
BACKGROUND/AIM: Etomidate, an intravenous anesthetic, has been shown to have anticancer effects, including induction of cell-cycle arrest and apoptosis. However, to our knowledge, there are no reports about the anti-metastasis effects of etomidate on A549 human lung adenocarcinoma cells.
MATERIALS AND METHODS: The cell viability, cell adhesion, gelatin zymography assay, transwell migration and invasion assay, and western blotting analysis were used to investigate the effects of etomidate on A549 cells.
RESULTS: In our study, etomidate showed low cytotoxicity, inhibited cell adhesion, and suppressed the migration and invasion in A549 cells. The activity of matrix metallopeptidase 2 (MMP2) was reduced by 48 h treatment of etomidate. Results of western blotting analysis indicated that etomidate down-regulated the expression of protein kinase C, MMP7, MMP1, MMP9, and p-p-38, but up-regulated that of RAS, phosphoinositide 3-kinase, and phosphor-extracellular-signal related kinase after 24 and 48 h treatment, in A549 cells.
CONCLUSION: Etomidate suppressed the migration and invasion of lung adenocarcinoma A549 cells via inhibiting the expression of MMP1, MMP2, MMP7 and MMP9, and provides potential therapeutic targets for lung cancer treatment.

PMID: 30591461 [PubMed - in process]

from A via a.sfakia on Inoreader http://bit.ly/2SqShLv